Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study-Reference-Cited by-同舟云学术

Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study

Published:2020-11-03 Issue:1 Volume:10 Page:269-280
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Tada Toshifumi^ORCID,Kumada Takashi,Okushin Hiroaki,Tani Joji,Takaguchi Koichi,Tsutsui Akemi,Toyoda Hidenori,Yasuda Satoshi,Dohmen Kazufumi,Hiraoka Atsushi,Michitaka Kojiro,Nouso Kazuhiro,Kariyama Kazuya,Kim Soo Ryang,Kim Soo Ki,Fujioka Shinichi,Mikami Shigeru,Watanabe Yuto,Tamai Tsutomu,Atsukawa Masanori,Itokawa Norio,Tanaka Hironori,Tsuji Kunihiko,Ishikawa Toru,Imai Michitaka,Itobayashi Ei,Shibata Hiroshi,Shimada Noritomo

Funder

Gilead Sciences

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-020-00364-9.pdf

Reference37 articles.

1. Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis c virus infection in 2015: a modelling study. Lancet GastroenterolHepatol. 2017;2:161–76.

2. Tateishi R, Uchino K, Fujiwara N, et al. A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update. J Gastroenterol. 2019;54:367–76.

3. Marcellin P, Boyer N, Gervais A, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med. 1997;127:875–81.

4. Shiffman ML, Hofmann CM, Thompson EB, et al. Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C. Hepatology. 1997;26:780–5.

5. Shiratori Y, Imazeki F, Moriyama M, et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med. 2000;132:517–24.